Our Participating Medicines
The Genentech medicines supported by the Genentech Patient Foundation are:
- Actemra® (tocilizumab)
- Activase® (alteplase)
- Alecensa® (alectinib)
- Avastin® (bevacizumab)
- Cathflo Activase® (alteplase)
- COLUMVI™ (glofitamab-gxbm)
- Cotellic® (cobimetinib)
- Enspryng™ (satralizumab-mwge)
- Erivedge® (vismodegib)
- Esbriet® (pirfenidone)
- Evrysdi™ (risdiplam)
- Gazyva® (obinutuzumab)
- Gavreto™ (Pralsetinib)
- Hemlibra® (emicizumab-kxwh)
- Herceptin® (trastuzumab)
- Herceptin Hylecta™ (trastuzumab and hyaluronidase-oysk)
- Kadcyla® (ado-trastuzumab emtansine)
- Lucentis™ (ranibizumab injection)
- LUNSUMIO™ (mosunetuzumab-axgb)
- Ocrevus® (ocrelizumab)
- Perjeta® (pertuzumab)
- Phesgo™ (pertuzumab, trastuzumab, and hyaluronidase-zzxf)
- Polivy™ (polatuzumab vedotin-piiq)
- Pulmozyme® (dornase alfa)
- Rituxan® (rituximab)
- Rituxan Hycela™ (rituximab and hyaluronidase human)
- Rozlytrek™ (entrectinib)
- Susvimo™ (ranibizumab injection)
- Tecentriq® (atezolizumab)
- TNKase® (tenecteplase)
- Vabysmo™ (faricimab)
- Venclexta® (venetoclax)
- Xolair® (omalizumab)
- Zelboraf® (vemurafenib)
Please Note: At this time, the Genentech Patient Foundation uses a separate process to support the following medicines:
- CELLCEPT® (mycophenolate mofetil)
- FUZEON® (enfuvirtide)
- NUTROPIN AQ® (somatropin)
- VALCYTE® (valganciclovir hydrochloride)
Learn more about support programs for these Genentech medicines here.
If you have been prescribed a participating medicine, you may qualify for support from the Genentech Patient Foundation. View the 'See If You Qualify' page to determine eligibility.
Support for Genentech medicines not listed above:
If you do not see your medicine listed, please contact our Patient Resource Center at 1 (877) GENENTECH (436-3683) for more information.